Position in BIIB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$393,907,620
+$24,312,698 QoQ
Shares Held
1,823,140
-9.6% QoQ
Ownership
1.23%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#12
of 1,037 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 2%
None 7%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $61,093,076,744 across 19 Drug Manufacturers - General names. BIIB ranks #10 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,598,524 | $15,111,048,894 | |
| 2 | JNJ |
Johnson & Johnson
|
58,301,609 | $14,806,859,626 | |
| 3 | ABBV |
AbbVie Inc.
|
47,862,796 | $12,044,193,975 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,886,420 | $5,639,404,964 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,713,442 | $4,132,128,518 | |
| 6 | AZN |
Astrazeneca PLC
|
19,204,823 | $3,641,618,528 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
20,820,621 | $2,630,477,247 | |
| 8 | AMGN |
Amgen Inc
|
3,588,484 | $1,299,461,817 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $393,907,620 | 1,823,140 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $369,594,922 | 2,016,009 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $326,859,533 | 1,857,262 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $177,670,460 | 1,268,350 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $125,904,218 | 1,002,502 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $200,295,438 | 1,463,720 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $320,568,326 | 2,096,314 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $1,019,079,480 | 5,257,323 | Shares | Sole | 2024-12-26 | |
| 2024-06-30 | $1,093,021,322 | 4,714,957 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $1,017,804,641 | 4,720,144 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $1,312,647,046 | 5,072,640 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $1,281,388,114 | 4,985,752 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $1,273,617,607 | 4,471,187 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $1,142,387,172 | 4,108,863 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $628,692,023 | 2,270,307 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $561,745,839 | 2,103,917 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $402,799,846 | 1,975,090 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $458,172,299 | 2,175,557 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $1,088,392,274 | 4,536,480 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $1,586,242,989 | 5,605,297 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $1,854,194,816 | 5,354,766 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $1,087,360,549 | 3,886,901 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $713,037,456 | 2,912,021 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $588,274,302 | 2,073,725 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $531,278,041 | 1,985,715 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $460,900,795 | 1,456,795 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||